Changing spectrum of invasive candidiasis and its therapeutic implications

Beck-Sague, 1993, Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990, J Infect Dis, 167, 1247, 10.1093/infdis/167.5.1247

Harbarth, 1999, Nosocomial infections in Swiss University hospitals: a multicentre survey and review of the published experience, Schweizerische Med Wochenscrift J Suisse Medecine, 129, 1521

Edmond, 1999, Nosocomial bloodstream infections in United States hospitals: a three-year analysis, Clin Infect Dis, 29, 239, 10.1086/520192

Rangel-Frausto, 1999, Variation in rates of Candida bloodstream infection in seven surgical ICUs and six neonatal ICUs, Clin Infect Dis, 29, 253, 10.1086/520194

Rentz, 1998, The impact of candidemia on length of hospital stay, outcome, and overall cost of illness, Clin Infect Dis, 27, 781, 10.1086/514955

Abi-Said, 1997, The epidemiology of hematogenous candidiasis caused by different Candida species, Clin Infectious Dis, 24, 1122, 10.1086/513663

Chen, 1981, Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993, Infect Cont Hospital Epid, 18, 369, 10.2307/30141234

Girmenia, 1998, Fluconazole and the changing epidemiology of candidemia, Clin Infect Dis, 27, 232, 10.1086/517694

Nguyen, 1996, The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance, Am J Med, 100, 617, 10.1016/S0002-9343(95)00010-0

Marr, 2000, Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogencic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial, Blood, 10.1182/blood.V96.6.2055

Chandrasekar, 1994, The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients, J Antimicrob Cherother, 33, 309, 10.1093/jac/33.2.309

Wingard, 1991, Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole, N Engl J Med, 325, 1274, 10.1056/NEJM199110313251803

Archibald, 1997, Antimicrobial resistance in isolates for inpatients and outpatients in the United States: increasing importance of the intensive care unit, Clin Infect Dis, 24, 211, 10.1093/clinids/24.2.211

Berrouane, 1999, Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital, J Clin Microbiol, 37, 531, 10.1128/JCM.37.3.531-537.1999

Gleason, 1997, Emerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care units, Arch Surg, 132, 197, 10.1001/archsurg.1997.01430350047008

Saiman, 2000, Risk factors for candidemia in Neonatal Intensive Care Unit patients, Pediar Infect Dis J, 19, 319, 10.1097/00006454-200004000-00011

Kossoff, 1998, Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases, Pediar Infect Dis J, 17, 504, 10.1097/00006454-199806000-00014

Marr, 2000, Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole, J Infect Dis, 181, 309, 10.1086/315193

Chandrasekar, 2000, Aspergillosis an increasing problem in tertiary care hospitals?, Clin Infect Dis, 30, 984, 10.1086/313832

van Burik, 1998, The effect of prophylactic fluconazole on the clinical spectrum of fungal diseaes in bone marrow transplant recipients with special attention to hepatic candidiasis, Medicine, 4, 246, 10.1097/00005792-199807000-00003

Einsele, 1995, Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation, Blood, 86, 2815, 10.1182/blood.V86.7.2815.2815

Castro J, Samore MH, Hadley S, Lewis HD, Jenkins RI, Karchmer AW. Development and validation of a prediction rule for invasive fungal infection in liver transplant recipients. 38th International Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA 1998. Abstract K-39.

Singh N, Linden PK, Munoz P, Dominguez EA. Emerging trends in invasive mold infections in organ transplant recipients. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada 2000. Abstract 1327.

Levy, 1998, Emergence of Candida parapsilosis's the predominant species causing candidemia in children, Clin Infect Dis, 26, 1086, 10.1086/520277

Mardani, 2000, Nosocomial Candida guilliermondii fungemia in cancer patients, Infect Cont Hospital Epid, 21, 336, 10.1086/501768

Meis, 1999, Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation, Emerg Infect Dis, 5, 150, 10.3201/eid0501.990119

Rex, 1994, A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia, New Engl J Med, 331, 1325, 10.1056/NEJM199411173312001

Anaissie, 1998, Predictors of adverse outcome in cancer patients with candidemia, Am J Med, 104, 238, 10.1016/S0002-9343(98)00030-8

Nguyen, 1995, Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective observational study, Arch Intern Med, 155, 2429, 10.1001/archinte.1995.00430220087009

Rex, 2000, Practice guidelines for the treatment of candidiasis, Clin Infect Dis, 30, 662, 10.1086/313749

Pfaller, 1998, National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of ocurrence and antifungal susceptibility in the SCOPE program, Diagn Microbiol Infect Dis, 30, 121, 10.1016/S0732-8893(97)00192-2

American Society of Clinical Microbiology, 1994, American Society of Clinical Microbiology recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines, J Clin Oncol, 12, 2471, 10.1200/JCO.1994.12.11.2471

Goodman, 1992, A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation, N Engl J Med, 326, 845, 10.1056/NEJM199203263261301

Slavin, 1995, Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind study, J Infect Dis, 171, 545, 10.1093/infdis/171.6.1545

Singh, 2000, Antifungal prophylaxis in organ transplant recipients: seeking clarity amidst controversy, Clin Infect Dis, 10.1086/313943

Stratta, 1998, Ganciclovir/acyclovir and fluconazole prophylaxis after simultaneous kidney-pancreas transplantation, Transplant Proceed, 30, 262, 10.1016/S0041-1345(97)01253-0

Tsai, 2000, Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole sensitive- and resistant-Candida species, Antimicrob Ag Chemother, 41, 2224, 10.1128/AAC.41.10.2224

Farina, 1999, Fungaemia survey: a 10-year experience in Bergamo, Italy, Mycoses, 42, 543, 10.1046/j.1439-0507.1999.00486.x

Pfaller, 2000, Bloodstream infections due to Candida species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997–1998, Antimicrob Ag Chemother, 44, 747, 10.1128/AAC.44.3.747-751.2000

Viscoli, 1999, Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC), Clin Infect Dis, 28, 1071, 10.1086/514731